P2X Purinoceptor 3 (P2RX3) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2021 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
P2X purinoceptor 3 is a protein encoded by the P2RX3 gene. It belongs to the family of purinoceptors. This receptor functions as a ligand-gated ion channel and transduce ATP-evoked nociceptor activation. This receptor is important for peripheral pain responses, and also participates in pathways controlling urinary bladder volume reflexes.
The P2X Purinoceptor 3 drugs in development market research report provides an in-depth analysis of P2X Purinoceptor 3 (P2RX3) targeted pipeline therapeutics. The report provides comprehensive information on the P2X Purinoceptor 3 (P2RX3) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases.
What are the therapy areas of the P2X Purinoceptor 3 pipeline drugs market?
The therapy areas of the P2X Purinoceptor 3 pipeline drugs market are the central nervous system, respiratory, dermatology, genitourinary system and sex hormones, ophthalmology, and women’s health.
P2X Purinoceptor 3 pipeline drugs market, by therapy areas
For more therapy area insights, download a free report sample
What are the indications of the P2X Purinoceptor 3 pipeline drugs market?
Some of the indications of the P2X Purinoceptor 3 pipeline drugs market are chronic cough, pain, cough, neuropathic pain (neuralgia), inflammatory pain, pruritus, visceral pain, Alzheimer’s disease, diabetic neuropathic pain, and endometriosis.
P2X Purinoceptor 3 pipeline drugs market, by indications
For more indication insights, download a free report sample
What are the mechanisms of action of the P2X Purinoceptor 3 pipeline drugs market?
The mechanism of action of the P2X Purinoceptor 3 pipeline drugs market is P2X Purinoceptor 3 Antagonist.
What are the routes of administration in the P2X Purinoceptor 3 pipeline drugs market?
The route of administration in the P2X Purinoceptor 3 pipeline drugs market is oral.
What are the molecule types in the P2X Purinoceptor 3 pipeline drugs market?
The molecule types in the P2X Purinoceptor 3 pipeline drugs market are small molecule, monoclonal antibody, and peptide.
P2X Purinoceptor 3 pipeline drugs market, by molecule types
For more molecule type insights, download a free report sample
Which are the key companies in the P2X Purinoceptor 3 pipeline drugs market?
Some of the key companies in the P2X Purinoceptor 3 pipeline drugs market are Merck & Co Inc, Asana BioSciences LLC, Bayer AG, Beijing Tide Pharmaceutical Co Ltd, BELLUS Health Inc, Future Analgesics, Integral Molecular Inc, Neurim Pharmaceuticals Ltd, Ossianix Inc, Shionogi & Co Ltd, and Sino Biopharmaceutical Ltd.
P2X Purinoceptor 3 pipeline drugs market, by key companies
To know more about key companies, download a free report sample
Market report scope
Therapy Areas | Central Nervous System, Respiratory, Dermatology, Genitourinary System and Sex Hormones, Ophthalmology, and Women’s Health |
Indications | Chronic Cough, Pain, Cough, Neuropathic Pain (Neuralgia), Inflammatory Pain, Pruritus, Visceral Pain, Alzheimer’s Disease, Diabetic Neuropathic Pain, and Endometriosis |
Mechanisms of Action | P2X Purinoceptor 3 Antagonist |
Routes of Administration | Oral |
Molecule Types | Small Molecule, Monoclonal Antibody, and Peptide |
Key Companies | Asana BioSciences LLC, Bayer AG, Beijing Tide Pharmaceutical Co Ltd, BELLUS Health Inc, Future Analgesics, Integral Molecular Inc, Merck & Co Inc, Neurim Pharmaceuticals Ltd, Ossianix Inc, Shionogi & Co Ltd, and Sino Biopharmaceutical Ltd |
This report provides:
- A snapshot of the global therapeutic landscape of P2X Purinoceptor 3 (P2RX3).
- Reviews of pipeline therapeutics for P2X Purinoceptor 3 (P2RX3) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Pipeline products based on several stages of development ranging from pre-registration to discovery and undisclosed stages.
- Descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- Key players involved in P2X Purinoceptor 3 (P2RX3) therapeutics and enlists all their major and minor projects.
- Assessment of P2X Purinoceptor 3 (P2RX3) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- Summaries of all the dormant and discontinued pipeline projects.
- Reviews of the latest news related to pipeline therapeutics for P2X Purinoceptor 3 (P2RX3).
Reasons to Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Identify and understand the targeted therapy areas and indications for P2X Purinoceptor 3 (P2RX3)Identify the use of drugs for target identification and drug repurposing.
- Identify potential new clients or partners in the target demographic.
- Develop strategic initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics.
- Devise corrective measures for pipeline projects by understanding P2X Purinoceptor 3 (P2RX3) development landscape.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
Bayer AG
Beijing Tide Pharmaceutical Co Ltd
BELLUS Health Inc
Future Analgesics
Integral Molecular Inc
Merck & Co Inc
Neurim Pharmaceuticals Ltd
Ossianix Inc
Shionogi & Co Ltd
Sino Biopharmaceutical Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What are the therapy areas of the P2X Purinoceptor 3 pipeline drugs market?
The therapy areas of the P2X Purinoceptor 3 pipeline drugs market are the central nervous system, respiratory, dermatology, genitourinary system and sex hormones, ophthalmology, and women’s health.
-
What are the indications of the P2X Purinoceptor 3 pipeline drugs market?
Some of the indications of the P2X Purinoceptor 3 pipeline drugs market are chronic cough, pain, cough, neuropathic pain (neuralgia), inflammatory pain, pruritus, visceral pain, Alzheimer’s disease, diabetic neuropathic pain, and endometriosis.
-
What are the mechanisms of action of the P2X Purinoceptor 3 pipeline drugs market?
The mechanism of action of the P2X Purinoceptor 3 pipeline drugs market is P2X Purinoceptor 3 Antagonist.
-
What are the routes of administration in the P2X Purinoceptor 3 pipeline drugs market?
The route of administration in the P2X Purinoceptor 3 pipeline drugs market is oral.
-
What are the molecule types in the P2X Purinoceptor 3 pipeline drugs market?
The molecule types in the P2X Purinoceptor 3 pipeline drugs market are small molecule, monoclonal antibody, and peptide.
-
Which are the key companies in the P2X Purinoceptor 3 pipeline drugs market?
Some of the key companies in the P2X Purinoceptor 3 pipeline drugs market are Asana BioSciences LLC, Bayer AG, Beijing Tide Pharmaceutical Co Ltd, BELLUS Health Inc, Future Analgesics, Integral Molecular Inc, Merck & Co Inc, Neurim Pharmaceuticals Ltd, Ossianix Inc, Shionogi & Co Ltd, and Sino Biopharmaceutical Ltd.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.